At QMISG, we believe that the future of MRI/S will be premised on formation of advance imaging and quantification technologies to investigate disease progression biomarkers. QMISG embraces an oriented educational and research base community to provide physicians, surgeons, radiologists and patients with excellent services such as facilitating diagnostic methods for disease early detection and providing a treatment planning based on every-day-growing science and technology. QMISG is a multi-disciplinary magnetic resonance quantification research group established in 2012 at the Research Center for Molecular and Cellular Imaging (RCMCI). MR imaging outcomes depend on knowledge and technology transfer in different levels, including clinical, imaging, research and educational centers. To this end, we aim to justify intensive educational activities in different levels. 
International Corporation
Compete Internationally
Creative Education
Education Precede Technology
Innovative Research
Results Driven Research
Accurate Clinical Services
Fast, Accurate & ReliableEducate To Elevate
Advanced Neuro MRI Course
0 Lessons
Advanced Cancer MRI Course
0 Lessons
Advanced Vascular MRI Course
0 Lessons
Intermediate MRI Course
0 Lessons
Basic MRI Course
0 Lessons
Authors M Shirin Shandiz, MH Aarabi, P Ghafarian, M Bakhshayesh Karam, H Saligheh Rad and M R Ay Conference...New Advances at QMISG
A Robust MR-Based Attenuation Map Generation in Short-TE MR Images of the Head Employing Hybrid Spatial Fuzzy C-Means Clustering and Intensity Inhomogeneity Correction
The activities of QMISG are concentrated on (but not dedicated to) cortical bone quantification using Short-TE MRI pulse sequences in various applications, e.g. quantification of Bone Water Concentration (BWC) or PET-MR attenuation map generation, analysis, quantification and processing of MRS signals in different diseases, such as brain tumors, multiple sclerosis, etc., analysis, quantification and method development in MR perfusion and diffusion studies (DSC-, DCE- MRI, and DTI) in brain and abdominal organs, analysis and quantification of whole-body MR images for treatment response follow-up, e.g. in metastatic bone marrow cancers, and protocol and Software development for various MRS/MRI applications. Magnetic Resonance Imaging/Spectroscopy for Oncological Applications Developing pre-clinical imaging protocols for treatment and surgical planning, prediction of tumor response to therapy, treatment response follow-up, and monitoring tumor progression in diverse clinical applications such as brain tumors, breast tumors, whole-body metastatic cancers in bone marrow or lymphoma, ovarian mass, etc. Biomarker development Developing advanced MR imaging techniques for identification of specific biomarkers, endpoints of in-vivo progression, and response to therapy in several diseases, such as cortical bone quantification in Osteoporosis. Applications of Neuroimaging Developing advanced anatomical and physiological MR imaging and spectroscopy quantification techniques for diagnosing neuro-pathologies such as multiple sclerosis, various brain tumors, epilepsy, stroke, etc.
The Quantitative Medical Imaging Systems Group (QMISG) is a multi-disciplinary magnetic resonance quantification research group established in 2012 at the Research Center for Molecular and Cellular Imaging (RCMCI). QMISG gathers interested researchers, scientists, and physicians who share a common concern in utilizing and developing novel imaging and computational technologies to provide a framework for accurate diagnosis of human diseases and monitoring the anatomical and physiological changes resulting from pathologies or in response to the planned treatment.
